Financhill
Sell
47

COLL Quote, Financials, Valuation and Earnings

Last price:
$29.95
Seasonality move :
-6.71%
Day range:
$29.56 - $30.40
52-week range:
$23.23 - $42.29
Dividend yield:
0%
P/E ratio:
24.56x
P/S ratio:
1.74x
P/B ratio:
4.11x
Volume:
424.4K
Avg. volume:
373.1K
1-year change:
-12.27%
Market cap:
$963M
Revenue:
$631.4M
EPS (TTM):
$1.22

Earnings Data

Next earnings date for COLL
Aug 08
2025
Most recent earnings per share
$0.07
Missed by $1.38
(May 8/2025)
Consensus Estimate
$1.45
(May 8/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

COLL Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
08/08/2025 Q2 $182.3M -- -- $1.83 --
05/08/2025 Q1 $173.1M $177.8M $0.07 $1.45 -$1.38
02/27/2025 Q4 $179.7M $181.9M $0.36 $1.54 -$1.18
11/07/2024 Q3 $155.6M $159.3M $0.27 $1.59 -$1.32
08/08/2024 Q2 $144.6M $145.3M $0.52 $1.49 -$0.97
05/09/2024 Q1 $146.9M $144.9M $0.71 $1.47 -$0.76
02/22/2024 Q4 $147.5M $149.7M $0.83 $1.26 -$0.43
11/03/2023 Q3 -- -- $0.53 $1.24 -$0.71
08/03/2023 Q2 -- -- $0.34 $1.22 -$0.88
05/04/2023 Q1 -- -- -$0.51 $1.51 -$2.02
02/23/2023 Q4 -- -- -$0.21 $1.26 -$1.47
11/03/2022 Q3 -- -- $0.01 $1.38 -$1.37
08/04/2022 Q2 -- -- -$0.15 $1.44 -$1.59
05/10/2022 Q1 -- -- -$0.39 $0.90 -$1.29
02/24/2022 Q4 -- -- -$0.73 $1.04 -$1.77
11/04/2021 Q3 -- -- $0.22 $0.96 -$0.74
08/05/2021 Q2 -- -- $1.79 $0.95 $0.84
05/06/2021 Q1 -- -- $0.41 $1.00 -$0.59
02/25/2021 Q4 -- -- $0.20 $0.97 -$0.77
11/05/2020 Q3 -- -- $0.32 $0.90 -$0.58
08/05/2020 Q2 -- -- $0.23 $0.86 -$0.63
05/07/2020 Q1 -- -- $0.01 $0.66 -$0.65
02/27/2020 Q4 -- -- -$0.07 $0.10 -$0.17
11/06/2019 Q3 -- -- -$0.18 $0.03 -$0.21
08/07/2019 Q2 -- -- $0.09 -$0.04 $0.14
05/08/2019 Q1 -- -- -$0.05 -$0.15 $0.09
02/27/2019 Q4 -- -- -$0.10 -$0.12 $0.02
11/08/2018 Q3 -- -- -$0.25 -$0.12 -$0.13
08/08/2018 Q2 -- -- -$0.15 -$0.33 $0.18
05/09/2018 Q1 -- -- -$0.57 -$0.65 $0.08
03/07/2018 Q4 -- -- -$0.54 -$0.55 $0.01
11/08/2017 Q3 -- -- -$0.45 -$0.73 $0.28
08/09/2017 Q2 -- -- -$0.72 -$0.81 $0.09
05/09/2017 Q1 -- -- -$0.79 -$1.00 $0.21
03/09/2017 Q4 -- -- -- -- --
11/10/2016 Q3 -- -- -- -- --
08/10/2016 Q2 -- -- -- -- --
05/10/2016 Q1 -- -- -- -- --
03/15/2016 Q4 -- -- -- -- --
11/12/2015 Q3 -- -- -- -- --
08/13/2015 Q2 -- -- -- -- --

Collegium Pharmaceutical Earnings Questions

  • How Much did Collegium Pharmaceutical Generate in Revenue Last Quarter?

    Collegium Pharmaceutical reported $177.8M worth of top line sales in its most recent quarter.

  • Did Collegium Pharmaceutical Beat Earnings Last Quarter?

    Collegium Pharmaceutical announced earnings per share of $0.07 which represents a miss of analyst forecast a $1.45 per share.

  • Is Collegium Pharmaceutical Profitable?

    Collegium Pharmaceutical reported $97.3M that represents $2.96 per share over the last quarter.

  • What is the Analyst Consensus for Collegium Pharmaceutical EPS Next Year?

    Collegium Pharmaceutical's earnings are forecast to grow from $1.86 per share to $6.18 per share next year representing an increase of 309.79%.

  • When is Collegium Pharmaceutical's Earnings Date?

    Collegium Pharmaceutical's next earnings date is August 8, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is GlobalFoundries On The Verge Of A Breakout?
Is GlobalFoundries On The Verge Of A Breakout?

GLOBALFOUNDRIES Inc. (NASDAQ:GFS) is as a semiconductor foundry whose chips…

Is Dick’s Sporting Goods Buying Foot Locker Smart?
Is Dick’s Sporting Goods Buying Foot Locker Smart?

Last week, Dick’s Sporting Goods (NYSE:DKS) announced that it would…

Is Ginkgo Bioworks Stock a Good Buy?
Is Ginkgo Bioworks Stock a Good Buy?

Biotech innovator Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) has had better…

Stock Ideas

Buy
70
Is MSFT Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 39x

Buy
71
Is NVDA Stock a Buy?

Market Cap: $3.3T
P/E Ratio: 46x

Sell
43
Is AAPL Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 34x

Alerts

Buy
55
RGC alert for May 21

Regencell Bioscience Holdings [RGC] is up 31.16% over the past day.

Buy
64
AKRO alert for May 21

Akero Therapeutics [AKRO] is up 24.59% over the past day.

Buy
76
AGYS alert for May 21

Agilysys [AGYS] is up 22.13% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock